Just in Time GCP is thrilled to announce the appointment of Aaron Grant as the new Head of Innovation, a newly created position designed to drive change within the clinical research industry. With a strong passion for industry transformation and a commitment to excellence, Aaron brings extensive experience and a forward-thinking mindset to the Just in Time GCP team. Must Consistently Raise Standards to Drive Excellence “Just in Time GCP is a highly regarded authority on best practices in clinical research; however, it’s essential to recognize that the definition of

  The Just in Time GCP Team At Just in Time GCP (JiT), our team members are integral to our mission of delivering top-tier GCP compliance and clinical research consulting services. This month, we’re shining the spotlight on one of ours, Ralf Brooks, who joined the JiT Team just four months ago, in July of 2024.  Ralf’s expertise in Good Clinical Practice (GCP) compliance, quality management systems, and clinical research continues to enhance our clients’ success.   Why did you decide to work at Just in Time GCP? “I joined

Insights from the 2024 Veeva R&D Summit Last week the Just in Time GCP team attended the Veeva R&D Summit in Boston where we proudly served as a Gold Sponsor. Veeva Summit was an exciting experience which provided an opportunity for attendees to engage with Veeva experts, partners, and users. It also offered a glimpse into the future of Veeva’s innovations and the evolving landscape of clinical operations. A recurring theme of this year’s summit was to ‘Simplify and Standardize’. Veeva leaders shared their vision of how we can achieve

“Processes and Practices Applicable to Bioresearch Monitoring Inspections: Guidance for Industry” is a draft guidance document issued by the FDA in June of this year. The intent is to provide clarity on the procedures and practices related to Bioresearch Monitoring (BIMO) inspections. This document is designed to help industry stakeholders understand what to expect during FDA inspections of sites and facilities involved in FDA-regulated research, ensuring compliance with statutory requirements and safeguarding the integrity of data and the welfare of clinical trial participants. It provides critical insights for industry stakeholders

Just in Time GCP is proud to announce its inclusion on the 2024 Inc. 5000 list, marking the fourth consecutive year the company has been recognized among America’s fastest-growing private companies.  “This achievement is a testament to the hard work the incredible JIT GCP Team has put in over the past several years, and the remarkable journey we are taking together.” says Founder & CEO Donna Dorozinsky.   The Inc. 5000 list is a prestigious ranking that highlights the most successful independent businesses in the U.S. The 2024 list showcases

Good Clinical Practice (GCP) is an international ethical and scientific quality standard for the design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials. It serves to protect the rights, integrity, and confidentiality of trial subjects. Ensuring compliance with GCP principles is crucial in clinical trials. This article will highlight four key reasons why following GCP compliance principles is essential. 1. Protects the Human Subject Compliance with GCP ensures that clinical research trials are conducted ethically, with informed consent from participants and appropriate oversight. Explanation Ethical conduct in